LSD shows promise for reducing anxiety in drugmaker’s midstage study

WASHINGTON — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for more than a half century. Read More